← ANALYSTS · TIPRANKS
Allison Bratzel · Piper Sandler
Hits
64%
110 of 171 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+41.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
21
Buy / hold / sell: 18 / 3 / 0
Upside of the analyst’s targets
+179.8%
Average over 21 current targets, to the last price
The market’s answer to the ratings
+3.5%
Day-0 move against SPY in the rating’s direction, average over 10 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 16on TipRanks 07:35 | ENGNenGene Holdings · $115M | Reiterated | Hold | $4.00 | +139.5% | −1.2% | ↗ |
| Sep 25on TipRanks 07:10 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Buy | $75.00 | +88.0% | −0.5%next day +1.8% · 5 days −3.5% | ↗ |
| Sep 8on TipRanks 07:25 | TYRAIWMTyra Bioscience · $1.3B | Reiterated | Buy | $56.00 | +202.4% | −6.2%next day −17.2% · 5 days −3.7% | ↗ |
| Sep 1on TipRanks 07:10 | BMRNBioMarin Pharmaceutical · $10.8B | Reiterated | Buy | $88.00 → $90.00+2.3% | +64.6% | +0.1%next day +2.8% · 5 days −0.7% | ↗ |
| Aug 17on TipRanks Aug 18 03:55 | CDXSIWMCodexis · $141M | Reiterated | Buy | $9.00 → $8.00−11.1% | +545.2% | +2.4%next day −5.0% · 5 days +5.6% | ↗ |
| Aug 17on TipRanks 07:38 | BHVNIWMBiohaven Ltd. · $1.7B | Reiterated | Buy | $30.00 | +178.3% | −0.8%next day −5.5% · 5 days −4.2% | ↗ |
| Aug 17on TipRanks 07:38 | IMRXIWMImmuneering · $235M | Reiterated | Buy | $12.00 | +234.3% | +3.6%next day −3.0% · 5 days +0.4% | ↗ |
| Aug 17on TipRanks 07:38 | RAREIWMUltragenyx Pharmaceutical · $1.5B | Reiterated | Buy | $68.00 | +367.7% | −0.9%next day −1.8% · 5 days −0.4% | ↗ |
| Aug 17on TipRanks 07:38 | AKBAIWMAkebia Therapeutics · $193M | Reiterated | Buy | $4.00 | +497.0% | −0.9%next day −0.4% · 5 days +5.8% | ↗ |
| Aug 17on TipRanks 07:38 | ALXOIWMALX Oncology Holdings · $138M | Reiterated | Buy | $4.00 | +277.4% | +1.0%next day +6.3% · 5 days +2.2% | ↗ |
| Aug 17on TipRanks 07:38 | IONSIonis Pharmaceuticals · $7.0B | Reiterated | Buy | $94.00 | +118.9% | +2.9%next day +2.4% · 5 days +7.0% | ↗ |
| Aug 17on TipRanks 07:38 | HUMAHumacyte · $139M | Reiterated | Hold | $1.00 | +133.1% | −6.8%next day +4.4% · 5 days +19.4% | ↗ |
| Aug 17on TipRanks 07:38 | MGTXIWMMeiragtx Holdings · $950M | Reiterated | Buy | $30.00 | +223.3% | +2.3%next day +1.5% · 5 days +8.9% | ↗ |
| Aug 17on TipRanks 07:22 | RIGLIWMRigel · $883M | Reiterated | Hold | $40.00 → $49.00+22.5% | +6.6% | +0.2%next day +3.4% · 5 days +7.5% | ↗ |
| Aug 17on TipRanks 07:22 | TVTXIWMTravere Therapeutics · $5.0B | Reiterated | Buy | $49.00 → $68.00+38.8% | +37.1% | +2.7%next day +1.3% · 5 days +3.9% | ↗ |
| Aug 17on TipRanks 07:20 | COGTIWMCogent Biosciences · $4.9B | Reiterated | Buy | $52.00 → $55.00+5.8% | +86.3% | +0.3%next day −0.6% · 5 days −3.1% | ↗ |
| Aug 17on TipRanks 07:20 | ARDXIWMArdelyx · $795M | Reiterated | Buy | $16.00 → $15.00−6.2% | +385.4% | +0.5%next day −2.8% · 5 days −6.7% | ↗ |
| Aug 17on TipRanks 07:20 | INCYSPYIncyte · $23.0B | Reiterated | Buy | $110 → $130+18.2% | +15.0% | +3.3%next day +0.7% · 5 days +4.8% | ↗ |
| Aug 17on TipRanks 07:20 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,075 → $1,215+13.0% | +48.3% | +16.5%next day +1.2% · 5 days +3.5% | ↗ |
| Aug 7on TipRanks 11:27 | REPLIWMReplimune Group · $1.1B | Reiterated | Buy | $14.00 | +28.9% | −6.8%next day +13.4% · 5 days +23.7% | ↗ |
| Jul 9on TipRanks 08:04 | ABVXAbivax SA Sponsored ADR · $8.6B | Assigned | Buy | $165 → $175+6.1% | +98.6% | +0.7%next day −1.0% · 5 days −2.0% | ↗ |
| May 8on TipRanks 05:15 | ENGNenGene Holdings · $115M | Downgrade | Hold | $7.00 → $4.00−42.9% | +139.5% | −13.6%next day −0.9% · 5 days +14.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗